A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent Glioblastoma
Status:
Not yet recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
This is a one arm, open, single center phase II study. The main purpose of this study was to
evaluate the efficacy and safety of fluzoparil combined with temozolomide in patients with
recurrent glioblastoma.